Hypercoagulable state in Cushing's syndrome: A systematic review

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2743-2750

  Van Zaane, Bregje ^a,b   Nur, Erfan ^a   Squizzato, Alessandro ^b,c   Dekkers, Olaf M ^d   Twickler, Marcel B ^b   Fliers, Eric ^b   Gerdes, Victor E A ^a,b   Büller, Harry R ^b   Brandjes, Dees P M ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; THROMBIN; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; CAUSE OF DEATH; CUSHING SYNDROME; DATA BASE; DATA EXTRACTION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERCORTISOLISM; INTERVENTION STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCORING SYSTEM; SYSTEMATIC REVIEW; VEIN THROMBOSIS;

EID: 68549125121     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0290     Document Type: Article

References (57)

1. Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen JH, Romijn JA 2007 Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92:976-981
2. Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484
3. Lindholm J, Juul S, Jørgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jørgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J 2001 Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123
4. Blichert-Toft M, Bagerskov A, Lockwood K, Hasner E 1972 Operative treatment, surgical approach, and related complications in 195 operations upon the adrenal glands. Surg Gynecol Obstet 135:261-266
5. Delaney JP, Solomkin JS, Jacobson ME, Doe RP 1978 Surgical management of Cushing's syndrome. Surgery 84:465-470
6. Pezzulich RA, Mannix Jr H 1970 Immediate complications of adrenal surgery. Ann Surg 172:125-130
7. Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT, Patrassi GM, Girolami A 2002 Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 87:3662-3666
8. Brotman DJ, Girod JP, Posch A, Jani JT, Patel JV, Gupta M, Lip GY, Reddy S, Kickler TS 2006 Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 118:247-252
9. Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, Blann AD 2005 High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost 94:797-801
10. Sjöberg HE, Blombäck M, Granberg PO 1976 Thromboembolic complications, heparin treatment in increase in coagulation factors in Cushing's syndrome. Acta Med Scand 199:95-98
11. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M 2008 Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454-2462
12. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW 2008 Prevention of venous thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 133:381S-453S
13. Rosendaal FR 1999 Venous thrombosis: a multicausal disease. Lancet 353:1167-1173
14. Hull R, van Aken WG, Hirsh J, Gallus AS, Hoicka G, Turpie AG, Walker I, Gent M 1976 Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis. Circulation 53:696-700
15. Wheeler HB, Pearson D, O'Connell D, Mullick SC 1972 Impedance phlebography: technique, interpretation, and results. Arch Surg 104:164-169
16. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P 2006 Newcastle-Ottawa scale. http://www.ohri.ca/programs/clinical- epidemiology/oxford.htm
17. 2006 Cochrane handbook for systematic reviews of intervention. The Cochrane Library. Oxford, UK: Update Software
18. Dal Bo Zanon R, Fornasiero L, Boscaro M, Cappellato G, Fabris F, Girolami A 1982 Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state. Thromb Haemost 47:116-117
19. Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM 2000 Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 23:145-150
20. Ikkala E, Myllylä G, Pelkonen R, Rasi V, Viinikka L, Ylikorkala O 1985 Haemostatic parameters in Cushing's syndrome. Acta Med Scand 217:507-511
21. Patrassi GM, Dal Bo Zanon R, Boscaro M, Martinelli S, Girolami A 1985 Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb Haemost 54:518-520
22. Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A 1992 The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 3:789-793
23. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G 2002 Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87:4872-4878
24. Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M, Aroasio E, Sacchetto G, Reimondo G, Angeli A, Camaschella C 2004 Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab 89:3745-3751
25. Chee GH, Mathias DB, James RA, Kendall-Taylor P 2001 Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin Endocrinol (Oxf) 54:617-626
26. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF 2002 Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56:541-551
27. Semple PL, Laws Jr ER 1999 Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J Neurosurg 91:175-179
28. Sirén J, Haglund C, Haapiainen R 2000 An institutional experience with 40 first lateral transperitoneal laparoscopic adrenalectomies. Surg Laparosc Endosc Percutan Tech 10:382-386
29. Small M, Lowe GD, Forbes CD, Thomson JA 1983 Thromboembolic complications in Cushing's syndrome. Clin Endocrinol (Oxf) 19:503-511
30. Sudhakar N, Ray A, Vafidis JA 2004 Complications after trans-sphenoidal surgery: our experience and a review of the literature. Br J Neurosurg 18:507-512
31. Zografos GN, Markou A, Ageli C, Kopanakis N, Koutmos S, Kaltsas G, Piaditis G, Papastratis G 2006 Laparoscopic surgery for adrenal tumors. A retrospective analysis. Hormones (Athens) 5:52-56
32. Patil CG, Lad SP, Harsh GR, Laws Jr ER, Boakye M 2007 National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Neurosurg Focus 23:E7
33. Huber O, Bounameaux H, Borst F, Rohner A 1992 Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 127:310-313
34. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W 1998 Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 158:1525-1531
35. Black PM, Zervas NT, Candia GL 1987 Incidence and management of complications of transsphenoidal operation for pituitary adenomas. Neurosurgery 20:920-924
36. Ciric I, Ragin A, Baumgartner C, Pierce D 1997 Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-236; discussion 236-237
37. Emeriau D, Vallee V, Tauzin-Fin P, Ballanger P 2005 [Morbidity of unilateral and bilateral laparoscopic adrenalectomy according to the indication. Report of a series of 100 consecutive cases]. Prog Urol 15:626-631
38. Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A 1997 Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg 226:238-246; discussion 246-247
39. Henry JF, Sebag F, Iacobone M, Hubbard J, Maweja S 2002 Lessons learned from 274 laparoscopic adrenalectomies [French]. Ann Chir 127:512-519
40. Porpiglia F, Destefanis P, Fiori C, Giraudo G, Garrone C, Scarpa RM, Fontana D, Morino M 2002 Does adrenal mass size really affect safety and effectiveness of laparoscopic adrenalectomy? Urology 60:801-805
41. Riche H, Jaboulay JM, Chiara Y, Peloux A 1992 Postoperative complications of trans-sphenoidal surgery [French]. Minerva Anestesiol 58(4 Suppl 1):71-72
42. Rutherford JC, Gordon RD, Stowasser M, Tunny TJ, Klemm SA 1995 Laparoscopic adrenalectomy for adrenal tumours causing hypertension and for 'incidentalomas' of the adrenal on computerized tomography scanning. Clin Exp Pharmacol Physiol 22:490-492
43. Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA 2002 Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 162:1465-1471
44. Eikelboom JW, Quinlan DJ, Douketis JD 2001 Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 358:9-15
45. Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, Henke PK 2007 Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 45:335-341, discussion 341-342
46. White RH, Zhou H, Romano PS 2003 Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 90:446-455
47. Anderson Jr FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE 1991 A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151:933-938
48. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton 3rd LJ 1998 Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585-593
49. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J 2007 Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692-699
50. Stassen JM, Arnout J, Deckmyn H 2004 The hemostatic system. Curr Med Chem 11:2245-2260
51. Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM 1999 Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 84:4097-4105
52. Healy AM, Gelehrter TD 1994 Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response. J Biol Chem 269:19095-19100
53. Morange PE, Aubert J, Peiretti F, Lijnen HR, Vague P, Verdier M, Négrel R, Juhan-Vague I, Alessi MC 1999 Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes 48:890-895
54. van Zonneveld AJ, Curriden SA, Loskutoff DJ 1988 Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci USA 85:5525-5529
55. Yamamoto Y, Ishizu A, Ikeda H, Otsuka N, Yoshiki T 2004 Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-α. Pathobiology 71:295-301
56. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB 2000 Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008-2012
57. Jüni P, Witschi A, Bloch R, Egger M 1999 The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282:1054-1060